Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care

por Hoffner, Brianna, Rubin, Krista M.
Publicado 2019

Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment

por Rubin, Krista M., Olszanski, Anthony J.
Publicado 2020

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer

por Emens, Leisha A, Adams, Sylvia, Cimino-Mathews, Ashley, Disis, Mary L, Gatti-Mays, Margaret E, Ho, Alice Y, Kalinsky, Kevin, McArthur, Heather L, Mittendorf, Elizabeth A, Nanda, Rita, Page, David B, Rugo, Hope S, Rubin, Krista M, Soliman, Hatem, Spears, Patricia A, Tolaney, Sara M, Litton, Jennifer K
Publicado 2021

Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy

por Zubiri, Leyre, Allen, Ian M., Taylor, Martin S., Guidon, Amanda C., Chen, Steven T., Schoenfeld, Sara R., Neilan, Tomas G., Sise, Meghan E., Mooradian, Meghan J., Rubin, Krista M., Leaf, Rebecca Karp, Parikh, Aparna R., Faje, Alexander, Gainor, Justin F., Cohen, Justine V., Fintelmann, Florian J., Kohler, Minna J., Dougan, Michael, Reynolds, Kerry L.
Publicado 2019

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0

por Pavlick, Anna C, Ariyan, Charlotte E, Buchbinder, Elizabeth I, Davar, Diwakar, Gibney, Geoffrey T, Hamid, Omid, Hieken, Tina J, Izar, Benjamin, Johnson, Douglas B, Kulkarni, Rajan P, Luke, Jason J, Mitchell, Tara C, Mooradian, Meghan J, Rubin, Krista M, Salama, April KS, Shirai, Keisuke, Taube, Janis M, Tawbi, Hussein A, Tolley, J Keith, Valdueza, Caressa, Weiss, Sarah A, Wong, Michael K, Sullivan, Ryan J
Publicado 2023

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

por Sullivan, Ryan J., Atkins, Michael B., Kirkwood, John M., Agarwala, Sanjiv S., Clark, Joseph I., Ernstoff, Marc S., Fecher, Leslie, Gajewski, Thomas F., Gastman, Brian, Lawson, David H., Lutzky, Jose, McDermott, David F., Margolin, Kim A., Mehnert, Janice M., Pavlick, Anna C., Richards, Jon M., Rubin, Krista M., Sharfman, William, Silverstein, Steven, Slingluff, Craig L., Sondak, Vernon K., Tarhini, Ahmad A., Thompson, John A., Urba, Walter J., White, Richard L., Whitman, Eric D., Hodi, F. Stephen, Kaufman, Howard L.
Publicado 2018

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

por Bai, Xue, Hu, Jiani, Betof Warner, Allison, Quach, Henry T., Cann, Christopher G., Zhang, Michael Z., Si, Lu, Tang, Bixia, Cui, Chuanliang, Yang, Xiaoling, Wei, Xiaoting, Pallan, Lalit, Harvey, Catriona, Manos, Michael P., Ouyang, Olivia, Kim, Michelle S., Kasumova, Gyulnara, Cohen, Justine V., Lawrence, Donald P., Freedman, Christine, Fadden, Riley M., Rubin, Krista M., Sharova, Tatyana, Frederick, Dennie T., Flaherty, Keith T., Rahma, Osama E., Long, Georgina V., Menzies, Alexander M., Guo, Jun, Shoushtari, Alexander N., Johnson, Douglas B., Sullivan, Ryan J., Boland, Genevieve M.
Publicado 2021

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

por Guidon, Amanda C, Burton, Leeann B, Chwalisz, Bart K, Hillis, James, Schaller, Teilo H, Amato, Anthony A, Betof Warner, Allison, Brastianos, Priscilla K, Cho, Tracey A, Clardy, Stacey L, Cohen, Justine V, Dietrich, Jorg, Dougan, Michael, Doughty, Christopher T, Dubey, Divyanshu, Gelfand, Jeffrey M, Guptill, Jeffrey T, Johnson, Douglas B, Juel, Vern C, Kadish, Robert, Kolb, Noah, LeBoeuf, Nicole R, Linnoila, Jenny, Mammen, Andrew L, Martinez-Lage, Maria, Mooradian, Meghan J, Naidoo, Jarushka, Neilan, Tomas G, Reardon, David A, Rubin, Krista M, Santomasso, Bianca D, Sullivan, Ryan J, Wang, Nancy, Woodman, Karin, Zubiri, Leyre, Louv, William C, Reynolds, Kerry L
Publicado 2021